Form 4: Procept BioRobotics CEO Exercises Stock Options, Increases Holdings
SEC Form 4 Filing
Reza Zadno, CEO of Procept BioRobotics, exercised stock options on May 9, 2025, acquiring 13,759 shares of common stock at $7.27 per share.
Summary
- On May 9, 2025, Reza Zadno, the President and CEO of Procept BioRobotics Corp, executed a transaction involving stock options.
- Zadno exercised options to acquire 13,759 shares of common stock at a price of $7.27 per share.
- Following this transaction, Zadno directly owns 186,829 shares of Procept BioRobotics Corp.
- Zadno also holds 158,871 derivative securities in the form of stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option exercise. The CEO exercising options can be seen as a mildly positive sign, but it's not a major event.
Positives
- The CEO's decision to exercise stock options could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings of company executives.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| June 22, 2021 | Date the stock option was granted. |
| 05/09/2025 | Date of the transaction (exercise of stock options). |
| 05/13/2025 | Date of signature on the Form 4 filing. |
| 06/21/2031 | Expiration date of the stock options. |
Keywords
PROCEPT BioRobotics, PRCT, Reza Zadno, Stock Options, Form 4, Beneficial Ownership, CEO, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.